NSEOutcome of Board Meeting▲ PositiveResults30 Oct 2026
Network18 Media & Investments Limited
Outcome of Board Meeting
Network18 Media & Investments Limited has submitted unaudited financial results for the quarter and half year ended 30th September, 2026, with a total income of ₹951.04 crore and a net profit of ₹446.05 crore.
BSECompany Update▲ PositiveResults30 Oct 2026
Menon Bearings Ltd-$
Announcement under Regulation 30 (LODR)- Investor Presentation
Menon Bearings Ltd. has released an investor presentation for Q2 & H1FY27, highlighting its financial and operational performance. The company has reported a 58.6% YoY increase in revenue from operations, a 103.8% YoY increase in EBITDA, and a 117.1% YoY increase in net profit. The presentation also provides a breakdown of the company's revenue and segment-wise performance.
NSEInvestor Presentation▲ PositiveResults30 Oct 2026
Privi Speciality Chemicals Limited
Investor Presentation
Privi Speciality Chemicals Limited has informed the Exchange about Investor Presentation for Q2 & H1 FY27 results, highlighting strong financial performance, resilience of business model, and disciplined execution.
BSECompany Update▲ PositiveResults30 Oct 2026
Privi Speciality Chemicals Ltd
Investor Presentation - Financial & Operational Review for Quarter and half year ended September 30,2026.
Privi Speciality Chemicals Ltd has released its investor presentation for Q2 and H1 FY27, showcasing strong financial performance with a 13.9% year-on-year growth in total income, 16.66% year-on-year growth in EBITDA, and 24.61% year-on-year growth in Net Profit. The company attributes its resilience to its diversified geographic presence and disciplined execution despite adverse global headwinds.
BSECompany Update▲ PositiveResults30 Oct 2026
Sun Pharmaceutical Industries Ltd
ILUMYA (tildrakizumab-asmm) approved in the U.S. for the treatment of adults with active Psoriatic Arthritis
Sun Pharmaceutical Industries Ltd announced the US FDA approval of ILUMYA (tildrakizumab-asmm) for the treatment of adults with active Psoriatic Arthritis, expanding the use of ILUMYA beyond moderate-to-severe plaque psoriasis.
BSECompany Update▲ PositiveResults30 Oct 2026
Fabtech Technologies Ltd
Please find attached Investor Presentation in relation to the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half- year ended September 30, 2026.
Fabtech Technologies Ltd has released its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026, with revenue and EBITDA (including other income) doubling QoQ to ₹155.7 mn in Q2 FY27, and management confident of achieving its FY27 Adjusted PAT margin objective of 8-9%.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults29 Oct 2026
Adani Total Gas Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Adani Total Gas Limited has announced its Q2 FY '27 earnings, with strong operational performance, 12% year-on-year EBITDA growth, and a resilient execution despite a challenging global energy environment.
BSECompany Update▲ PositiveResults29 Oct 2026
Adani Total Gas Ltd
Transcript of Earning Call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026
Adani Total Gas Ltd reported strong operational performance for the quarter and half year ended September 30, 2026, with Q2 FY '27 volumes growing 12% year-on-year to 315 MMSCM and EBITDA increasing 12% to INR340 crores. For half year ended 30th September 2026, volumes grew 13% to 618 MMSCM and EBITDA rose 3% to INR621 crores.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults29 Oct 2026
DCB Bank Limited
Analysts/Institutional Investor Meet/Con. Call Updates
DCB Bank Limited has announced its Q2 FY27 earnings, with net interest income growing by 17% Y-o-Y, advances growing by 21% Y-o-Y, and deposits growing by 19%. The bank's net profit has risen by 29% over the year to INR 236 crores, the highest ever in a quarter. The bank has also achieved a 7.23% improvement in PCR and a 9.6% improvement in PCR excluding technical write-off.
BSECompany Update▲ PositiveResults29 Oct 2026
DCB Bank Ltd
Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the transcript of the Earnings Conference Call held on October 23, 2026 with respect to the Unaudited Financial Results of DCB Bank Limited ('the Bank') for the quarter and half year ended September 30, 2026. The same has also been uploaded on website of the Bank and can be accessed at the link given in the letter.
DCB Bank Ltd reported Q2FY27 results with 21% Y-o-Y growth in advances, 19% Y-o-Y growth in deposits, and 17% Y-o-Y growth in net interest income. Net profit rose by 29% over the year to INR 236 crores, the highest ever in a quarter. The bank's ROA and ROE were 1.03% and 14.6% respectively for the quarter, and 1% and 14.12% respectively for the half year.
BSECompany Update▲ PositiveResults29 Oct 2026
Suryoday Small Finance Bank Ltd
Please find attached herewith Investor Presentation on the Unaudited Financial Results of the Bank for the Quarter and Half year ended on September 30, 2026
Suryoday Small Finance Bank Ltd has released its unaudited financial results for the quarter and half year ended September 30, 2026, showing a 34.6% YoY growth in gross advances and a 35.0% YoY growth in deposits. The bank has also announced its guidance for FY27, targeting a 25% YoY growth in IF advances and a 30-35% growth in deposits.
NSEGeneral Updates▲ PositiveResults29 Oct 2026
Alldigi Tech Limited
General Updates
Alldigi Tech Limited has submitted its Q2 FY27 earnings update, reporting a 28.5% YoY increase in EBITDA to ₹46.3 Cr, with margins expanding by 576bps Y-o-Y to 30.2%. The company also launched its unified HRMS, employee self-service and payroll product, Buzzily 2.0, and its India HR suite and end-to-end HR analytics tool, Alldigi 360 & Alldigi 360 - Analytics.
NSEInvestor Presentation▲ PositiveResults29 Oct 2026
Suryoday Small Finance Bank Limited
Investor Presentation
Suryoday Small Finance Bank Limited has released its Q2FY27 and H1FY27 financial results, showing a significant increase in loan disbursements, advances, and deposits. The bank has also reported a substantial growth in its retail asset business, with a 34.6% YoY increase in loan book and a 27.4% YoY increase in disbursements. The bank's profitability has also improved, with a 151.7% YoY increase in PAT and a 83.8% YoY increase in PPOP.
BSECompany Update▲ PositiveResults29 Oct 2026
Alldigi Tech Ltd
Investor Presentation
Alldigi Tech Ltd has announced its Q2 FY27 earnings, with EBITDA increasing 28.5% YoY to ₹46.3 Cr and margins expanding by 576bps Y-o-Y to 30.2%. The company has also launched new products and services, including a unified HRMS and employee self-service product.
NSEPress Release▲ PositiveResults29 Oct 2026
Alldigi Tech Limited
Press Release
Alldigi Tech Limited has announced its Q2FY27 financial results, with PAT up 50.9% YoY to ₹26.6 Cr, EBITDA up 28.5% YoY to ₹46.3 Cr, and EBITDA margin expanding 576 bps YoY to 30.2%. The company also announced a ₹48 Cr share buyback at ₹1,000 per share.
BSECompany Update▲ PositiveResults29 Oct 2026
Alldigi Tech Ltd
Press Release
Alldigi Tech Ltd reported strong Q2FY27 results with PAT up 50.9% YoY to ₹26.6 Cr, EBITDA up 28.5% YoY to ₹46.3 Cr, and EBITDA margin expanding 576 bps YoY to 30.2%. The company also announced a ₹48 Cr share buyback at ₹1,000 per share subject to shareholder approval.
NSEGeneral Updates▲ PositiveResults29 Oct 2026
Deepak Nitrite Limited
General Updates
Deepak Nitrite Limited has reported its Q2 and H1 FY2027 results, achieving a highest-ever quarterly and first-half performance with revenue and profitability growth.
BSECompany Update▲ PositiveResults29 Oct 2026
RPG Life Sciences Ltd
Press Release
RPG Life Sciences Ltd reported Q2 FY27 revenue growth of 16.5% to ₹211.6 crore, with adjusted EBITDA growing 15% to ₹50.1 crore. The company achieved a healthy gross margin expansion of 260 bps in Q2 and crossed the ₹200 crore quarterly revenue milestone.
NSEPress Release▲ PositiveResults29 Oct 2026
RPG Life Sciences Limited
Press Release
RPG Life Sciences Limited has announced its financial results for H1 and the quarter ended on 30th September, 2026, with revenue from operations growing 16.5% to ₹211.6 crore and adjusted EBITDA growing 15% to ₹50.1 crore.
BSECompany Update▲ PositiveResults29 Oct 2026
Deepak Nitrite Ltd-$
Q2 & H1 FY 2026-2027 Results Presentation
Deepak Nitrite Ltd has reported its Q2 and H1 FY 2027 results, achieving highest-ever quarterly and first-half performance with revenue and profitability growth of 61% and 187% YoY respectively.